Physician profile
Karan Singh
NPI 1265797161
$13,499.38
in general payments reported to CMS, 2019-2025
43 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $291 · 2021: $357 · 2022: $1,252 · 2023: $7,891 · 2024: $2,489 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,090 · Food and Beverage: $2,810 · Travel and Lodging: $1,570 · Honoraria: $750 · Gift: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,089.99 |
| Food and Beverage | $2,809.78 |
| Travel and Lodging | $1,569.71 |
| Honoraria | $750.00 |
| Gift | $202.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,016.29 | 2023-2024 | Da Vinci Surgical System |
| Pulmonx Corporation | $889.76 | 2020-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Cook Incorporated | $750.00 | 2024 | |
| Glaxosmithkline, LLC. | $548.28 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Noah Medical Corporation | $477.55 | 2025 | Galaxy |
| Astrazeneca Pharmaceuticals LP | $426.84 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Actelion Pharmaceuticals US, INC. | $272.97 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $221.57 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $173.21 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $168.17 | 2021-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $146.76 | 2022-2024 | Zerbaxa, Dificid, Recarbrio |
| Olympus America INC. | $126.01 | 2024-2025 | Single-Use Flexible Video Bronchoscope, Spiration Valve System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.72 | 2019-2024 | Jardiance, Ofev |
| Veran Medical Technologies, INC. | $117.92 | 2019-2021 | |
| Insmed, INC. | $116.09 | 2020-2024 | Arikayce |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.